
From law firm to FDA chief-in-waiting: Diamantas defies expectations
Acting FDA commissioner Kyle Diamantas, a former Jones Day attorney with no public-health or government background, has defied early doubts by earning the trust of FDA career staff and signaling a different leadership approach at Marty Makary’s FDA during a period of upheaval.









